← All diseases

Inborn errors of metabolism

Classic galactosemia

An inherited problem with processing sugar. The body cannot use galactose, a sugar found in milk. If not treated, severe liver problems begin in the baby in the first days.

Not part of the panel of Türkiye's National Newborn Screening Programme (heel-prick test). Source

Orphanet has a guideline for emergency doctors for this disease (language: French). See on Orphanet

Prepare an emergency card

This page is translated from the Turkish original.

This disease is followed through the “Inborn errors of metabolism” group.

Understanding the disease

This section has not yet been reviewed by a physician. It summarises patient information from sources such as MedlinePlus, Orphanet and the NHS in plain language. The disease can differ from person to person; talk to your doctor about diagnosis and treatment.

What happens in this disease?

Galactose is part of milk sugar. It is found in breast milk and dairy products. In this disease, the enzyme that breaks down galactose hardly works at all. Galactose and its by-products build up and damage the liver, brain, eyes and kidneys.

Which symptoms can occur?

The baby looks healthy at birth. Once the baby starts having milk, symptoms can appear within a few days.

  • Difficulty sucking and vomiting
  • Weakness and poor weight gain
  • Jaundice and liver damage
  • A tendency to bleed
  • Severe blood infection
  • Cataract in the eye, meaning clouding of the lens
  • Later, difficulty with speech and learning
  • Early failure of the ovaries in girls (very common)

How is it diagnosed?

In many countries, it is found through newborn heel-prick screening. Enzyme activity and galactose products are measured in red blood cells. The diagnosis is supported by a genetic test.

Treatment and care

The most important step is to start a diet without milk sugar right away. Instead of breast milk and regular formula, a galactose-free formula is given. The diet is lifelong. Speech therapy, educational support and hormone support may be needed. Development and the eyes are checked regularly. New medicines specific to the disease are being researched. The doctor who follows the disease decides which treatment is suitable.

For the family: inheritance and genetic counselling

The disease is passed on through recessive inheritance. The mother and father are usually healthy carriers. For a couple who are both carriers, the chance of having an affected child is 1 in 4 in each pregnancy. When relatives marry, the chance that two carriers have children together is higher. Genetic counselling guides the family.

Source: MedlinePlus Genetics: Galactosemia · NORD: Galactosemia

Key facts

How common is it?
New cases per year: 1-9 per 100 000 (Europe)
How is it inherited?
Autosomal recessive
When does it usually start?
Infancy, Newborn period
Gene(s) involved
GALT

These facts are taken from Orphanet and MedlinePlus records (last checked: October 7, 2026). Frequency values are approximate ranges.

You are not alone: patient associations in Türkiye

Non-profit patient and family organizations in Türkiye working on this disease or disease group. Links are for information; Doktorclub is not affiliated with these organizations and does not endorse them.

We could not find a patient association specific to this disease.

For all rare diseases: Nadir Hastalıklar Federasyonu

Guides related to this disease

  • Special diets and medical nutrition · Metabolic diet, blood monitoring, medical formula and SGK report, sick-day plan, tube feeding and swallowing problems, school meals, supplement warning
  • Rare disease at school · Telling the school, medicines and emergency plan, inclusion and BEP, support education room, absences, LGS/YKS arrangements, peer bullying.

Support and help

Doktorclub does not diagnose, recommend treatments or refer you to hospitals or doctors. These pages are meant to help you talk with your doctor.

News about Galactosemia

Clinical trials (ClinicalTrials.gov)

A clinical trial is a regulated study that tests whether a new treatment is safe and whether it works, in patients who volunteer. Most trials look for a certain age, genetic change and health condition. Taking part is voluntary.

This list is not a treatment recommendation. Treatments tested in phase 1–3 trials are investigational (experimental): their efficacy and safety have not yet been proven and they are not approved treatments. Taking part depends on each trial’s criteria and a physician’s assessment; the first step is to talk to the doctor who manages your care.

ClinicalTrials.gov currently lists no active interventional studies for this disease. Last checked: October 7, 2026.

See all studies on ClinicalTrials.gov · Joining clinical trials

Inborn errors of metabolism: other news

Medical codes (for talking with your doctor and finding sources)

These codes identify the disease in international classifications and databases. They can help when you talk with your doctor or look for reliable sources.

Orphanet code: ORPHA:79239 · ICD-11 5C51.40

Codes checked against WHO ICD-11 and Orphanet on October 7, 2026.

This page provides general information and does not replace diagnosis or treatment. Talk to your doctor about symptoms, diagnosis and treatment.

The information on these pages is for general information only and does not replace medical advice. Talk to your doctor about diagnosis and treatment decisions. In an emergency in Türkiye, call 112.

Every update is based on an open source and labeled with its level of evidence. No advertising and no drug brand names. Our scientific principles

This page was translated from Turkish by the Doktorclub editorial team.